Liposome-encapsulated plasmid DNA of telomerase-specific oncolytic adenovirus with stealth effect on the immune system

Oncolytic virotherapy has the disadvantage of being unsuitable for systemic delivery due to immune elimination. Liposomal encapsulation is well-recognized to reduce immune elimination and enhance the stability of drugs in the bloodstream. In the present study, the potential of liposome-encapsulated...

Descripción completa

Detalles Bibliográficos
Autores principales: Aoyama, Katsuyuki, Kuroda, Shinji, Morihiro, Toshiaki, Kanaya, Nobuhiko, Kubota, Tetsushi, Kakiuchi, Yoshihiko, Kikuchi, Satoru, Nishizaki, Masahiko, Kagawa, Shunsuke, Tazawa, Hiroshi, Fujiwara, Toshiyoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658411/
https://www.ncbi.nlm.nih.gov/pubmed/29074882
http://dx.doi.org/10.1038/s41598-017-14717-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5658411/
https://www.ncbi.nlm.nih.gov/pubmed/29074882
http://dx.doi.org/10.1038/s41598-017-14717-x

Ejemplares similares